|
Females
|
Total Māori
|
Total Pacific
|
European/Other
|
|---|
|
Follow-up period
|
Mortality
|
Standardized rate (per 100,000)
|
Standardized rate difference (per 100,000)
|
Standardized rate ratio
|
Standardized rate (per 100,000)
|
Standardized rate difference (per 100,000)
|
Standardized rate ratio
|
Standardized rate (per 100,000)
|
|---|
|
1981–1984
|
All-cause
|
692 (642 - 742)
|
389.5 (339.0 - 440.0)
|
2.29 (2.12 - 2.47)
|
389 (315 - 462)
|
86.6 (12.7 - 160.4)
|
1.29 (1.06 - 1.56)
|
302 (296 - 309)
|
|
1986–1989
|
626 (585 - 668)
|
347.3 (305.5 - 389.1)
|
2.25 (2.09 - 2.41)
|
425 (359 - 491)
|
146.0 (79.4 - 212.7)
|
1.52 (1.30 - 1.78)
|
279 (273 - 285)
|
|
1991–1994
|
612 (575 - 649)
|
365.4 (328.1 - 402.7)
|
2.48 (2.33 - 2.65)
|
386 (336 - 436)
|
139.7 (89.6 - 189.8)
|
1.57 (1.37 - 1.79)
|
246 (241 - 252)
|
|
1996–1999
|
597 (566 - 629)
|
382.4 (350.8 - 414.0)
|
2.78 (2.63 - 2.94)
|
393 (352 - 434)
|
178.1 (136.9 - 219.3)
|
1.83 (1.64 - 2.03)
|
215 (210 - 220)
|
|
2001–2006
|
571 (548 - 593)
|
363.7 (341.0 - 386.4)
|
2.76 (2.64 - 2.88)
|
356 (328 - 383)
|
148.7 (120.9 - 176.5)
|
1.72 (1.59 - 1.86)
|
207 (203 - 211)
|
|
2006–2011
|
475 (457 - 494)
|
300.7 (282.1 - 319.4)
|
2.72 (2.61 - 2.84)
|
348 (324 - 372)
|
173.0 (148.8 - 197.1)
|
1.99 (1.85 - 2.14)
|
175 (171 - 178)
|
|
Change p.a. (%)
| |
-1.16
| | |
-0.59
| | |
-2.04
|
|
P Trend
|
0.01
|
0.11
|
0.03
|
0.02
|
0.13
|
0.02
|
<0.01
|
|
1981–1984
|
CVD
|
304 (270 - 338)
|
185.4 (151.2 - 219.7)
|
2.57 (2.28 - 2.88)
|
158 (112 - 203)
|
39.2 (-6.9 - 85.2)
|
1.33 (0.99 - 1.78)
|
118 (114 - 122)
|
|
1986–1989
|
258 (231 - 285)
|
162.3 (134.7 - 190.0)
|
2.70 (2.41 - 3.02)
|
167 (121 - 213)
|
70.9 (24.8 - 117.0)
|
1.74 (1.32 - 2.30)
|
96 (92 - 99)
|
|
1991–1994
|
228 (204 - 252)
|
154.5 (130.5 - 178.6)
|
3.10 (2.77 - 3.47)
|
149 (116 - 181)
|
74.9 (42.3 - 107.5)
|
2.02 (1.62 - 2.52)
|
74 (71 - 76)
|
|
1996–1999
|
201 (182 - 219)
|
148.7 (129.9 - 167.5)
|
3.87 (3.49 - 4.29)
|
129 (106 - 152)
|
77.3 (53.8 - 100.7)
|
2.49 (2.07 - 3.00)
|
52 (50 - 54)
|
|
2001–2006
|
169 (157 - 182)
|
124.7 (111.9 - 137.4)
|
3.79 (3.49 - 4.13)
|
109 (93 - 125)
|
64.1 (48.1 - 80.0)
|
2.43 (2.09 - 2.83)
|
45 (43 - 46)
|
|
2006–2011
|
124 (115 - 134)
|
93.8 (83.9 - 103.8)
|
4.07 (3.71 - 4.46)
|
91 (78 - 103)
|
60.2 (47.7 - 72.8)
|
2.97 (2.57 - 3.43)
|
31 (29 - 32)
|
|
Change p.a. (%)
| |
-3.06
| | |
-2.18
| | |
-5.02
|
|
P Trend
|
<0.01
|
<0.01
|
<0.01
|
<0.01
|
0.64
|
<0.01
|
<0.01
|
|
1981–1984
|
Lung cancer
|
56 (41 - 70)
|
43.7 (29.0 - 58.3)
|
4.62 (3.49 - 6.12)
| | | |
12 (11 - 13)
|
|
1986–1989
|
55 (43 - 67)
|
40.7 (28.7 - 52.8)
|
3.93 (3.09 - 4.99)
|
19 (4 - 34)
|
5.1 (-9.6 - 19.9)
|
1.37 (0.63 - 2.97)
|
14 (13 - 15)
|
|
1991–1994
|
58 (47 - 69)
|
43.0 (31.9 - 54.0)
|
3.78 (3.08 - 4.65)
|
12 (4 - 21)
|
-3.1 (-11.8 - 5.7)
|
0.80 (0.40 - 1.62)
|
15 (14 - 17)
|
|
1996–1999
|
69 (58 - 80)
|
53.2 (42.1 - 64.2)
|
4.35 (3.64 - 5.20)
|
21 (11 - 32)
|
5.5 (-5.1 - 16.0)
|
1.34 (0.82 - 2.21)
|
16 (15 - 17)
|
|
2001–2006
|
74 (66 - 82)
|
57.0 (48.6 - 65.3)
|
4.31 (3.80 - 4.90)
|
26 (18 - 33)
|
8.6 (0.9 - 16.3)
|
1.50 (1.11 - 2.03)
|
17 (16 - 18)
|
|
2006–2011
|
65 (58 - 71)
|
48.5 (41.8 - 55.2)
|
4.01 (3.56 - 4.52)
|
20 (15 - 26)
|
4.3 (-1.5 - 10.0)
|
1.26 (0.95 - 1.68)
|
16 (15 - 17)
|
|
Change p.a. (%)
| |
1.02
| | |
1.5
| | |
1.2
|
|
P Trend
|
0.17
|
0.24
|
0.79
|
0.04
|
0.06
|
0.42
|
0.02
|
|
1981–1984
|
Non-lung cancer
|
127 (107 - 147)
|
28.5 (8.6 - 48.5)
|
1.29 (1.10 - 1.51)
|
95 (59 - 130)
|
-3.8 (-39.7 - 32.0)
|
0.96 (0.66 - 1.40)
|
99 (95 - 102)
|
|
1986–1989
|
122 (105 - 139)
|
25.6 (8.3 - 42.9)
|
1.27 (1.10 - 1.46)
|
105 (72 - 138)
|
8.4 (-24.9 - 41.6)
|
1.09 (0.79 - 1.49)
|
97 (93 - 100)
|
|
1991–1994
|
123 (107 - 138)
|
29.1 (13.3 - 44.8)
|
1.31 (1.15 - 1.49)
|
90 (67 - 113)
|
-4.0 (-27.1 - 19.2)
|
0.96 (0.74 - 1.24)
|
94 (90 - 97)
|
|
1996–1999
|
139 (125 - 153)
|
49.8 (35.0 - 64.6)
|
1.56 (1.40 - 1.74)
|
115 (92 - 138)
|
26.2 (3.0 - 49.3)
|
1.29 (1.06 - 1.58)
|
89 (86 - 92)
|
|
2001–2006
|
139 (128 - 150)
|
53.7 (42.8 - 64.6)
|
1.63 (1.50 - 1.77)
|
100 (86 - 114)
|
14.6 (0.2 - 29.1)
|
1.17 (1.01 - 1.36)
|
85 (83 - 88)
|
|
2006–2011
|
137 (128 - 147)
|
60.8 (50.9 - 70.8)
|
1.80 (1.66 - 1.94)
|
114 (101 - 128)
|
37.9 (24.3 - 51.6)
|
1.50 (1.33 - 1.69)
|
77 (74 - 79)
|
|
Change p.a. (%)
| |
0.49
| | |
0.6
| | |
-0.9
|
|
P Trend
|
0.06
|
<0.01
|
<0.01
|
0.22
|
0.05
|
0.04
|
<0.01
|
|
1981–1984
|
Respiratory disease
|
62 (47 - 76)
|
47.7 (33.3 - 62.1)
|
4.43 (3.44 - 5.70)
|
21 (6 - 36)
|
7.0 (-8.1 - 22.2)
|
1.50 (0.73 - 3.12)
|
14 (13 - 15)
|
|
1986–1989
|
67 (53 - 82)
|
51.6 (37.0 - 66.1)
|
4.31 (3.41 - 5.45)
|
34 (18 - 49)
|
18.0 (2.8 - 33.2)
|
2.16 (1.36 - 3.42)
|
16 (14 - 17)
|
|
1991–1994
|
57 (45 - 69)
|
43.3 (31.2 - 55.4)
|
4.12 (3.28 - 5.17)
|
25 (12 - 38)
|
11.1 (-2.5 - 24.6)
|
1.80 (1.04 - 3.10)
|
14 (13 - 15)
|
|
1996–1999
|
52 (43 - 62)
|
38.7 (29.0 - 48.4)
|
3.82 (3.12 - 4.68)
|
15 (8 - 23)
|
1.5 (-6.3 - 9.4)
|
1.11 (0.66 - 1.86)
|
14 (13 - 15)
|
|
2001–2006
|
58 (51 - 66)
|
43.8 (36.3 - 51.4)
|
4.01 (3.47 - 4.64)
|
19 (13 - 25)
|
4.4 (-1.8 - 10.6)
|
1.31 (0.94 - 1.81)
|
15 (14 - 16)
|
|
2006–2011
|
51 (44 - 57)
|
38.3 (31.9 - 44.8)
|
4.16 (3.59 - 4.81)
|
20 (14 - 26)
|
7.5 (1.6 - 13.5)
|
1.62 (1.19 - 2.20)
|
12 (11 - 13)
|
|
Change p.a. (%)
|
-0.81
| | |
-1.4
| | |
-0.32
|
|
P Trend
|
0.1
|
0.09
|
0.37
|
0.46
|
0.66
|
0.4
|
0.17
|
|
1981–1984
|
Diabetes
|
34 (21 - 46)
|
29.2 (16.8 - 41.7)
|
7.84 (5.17 - 11.89)
|
33 (7 - 59)
|
28.8 (3.0 - 54.7)
|
7.75 (3.47 - 17.32)
|
4 (4 - 5)
|
|
1986–1989
|
34 (23 - 44)
|
29.2 (18.8 - 39.6)
|
7.70 (5.40 - 10.98)
|
24 (9 - 39)
|
19.7 (4.4 - 34.9)
|
5.52 (2.86 - 10.65)
|
4 (4 - 5)
|
|
1991–1994
|
49 (38 - 60)
|
45.3 (34.5 - 56.0)
|
13.43 (10.11 - 17.85)
|
25 (11 - 38)
|
20.9 (7.4 - 34.4)
|
6.74 (3.78 - 12.02)
|
4 (3 - 4)
|
|
1996–1999
|
47 (38 - 57)
|
44.1 (34.7 - 53.6)
|
15.98 (12.15 - 21.01)
|
45 (31 - 59)
|
42.3 (28.2 - 56.5)
|
15.36 (10.68 - 22.10)
|
3 (2 - 4)
|
|
2001–2006
|
45 (38 - 51)
|
40.9 (34.4 - 47.3)
|
12.29 (10.07 - 15.01)
|
43 (33 - 52)
|
38.9 (29.3 - 48.4)
|
11.74 (9.01 - 15.30)
|
4 (3 - 4)
|
|
2006–2011
|
28 (24 - 33)
|
25.4 (20.9 - 29.9)
|
9.61 (7.75 - 11.91)
|
40 (32 - 49)
|
37.2 (28.5 - 45.9)
|
13.62 (10.50 - 17.66)
|
3 (3 - 3)
|
|
Change p.a. (%)
| |
0.06
| | |
1.75
| | |
-2.52
|
|
P Trend
|
0.41
|
0.47
|
0.88
|
0.11
|
0.1
|
0.18
|
0.07
|
|
1981–1984
|
Unintentional injury
|
25 (18 - 31)
|
8.1 (1.7 - 14.5)
|
1.49 (1.14 - 1.96)
|
15 (2 - 27)
|
-1.8 (-14.7 - 11.1)
|
0.89 (0.37 - 2.16)
|
16 (15 - 18)
|
|
1986–1989
|
27 (20 - 33)
|
11.1 (4.4 - 17.7)
|
1.71 (1.31 - 2.22)
|
16 (9 - 24)
|
0.6 (-7.2 - 8.3)
|
1.04 (0.64 - 1.67)
|
16 (14 - 17)
|
|
1991–1994
|
28 (21 - 34)
|
14.8 (8.2 - 21.3)
|
2.14 (1.66 - 2.77)
|
14 (7 - 21)
|
1.0 (-6.0 - 8.0)
|
1.08 (0.65 - 1.78)
|
13 (12 - 14)
|
|
1996–1999
|
21 (17 - 26)
|
11.1 (6.3 - 15.9)
|
2.11 (1.64 - 2.72)
|
10 (5 - 16)
|
0.2 (-5.3 - 5.7)
|
1.02 (0.59 - 1.75)
|
10 (9 - 11)
|
|
2001–2006
|
22 (18 - 26)
|
12.9 (9.1 - 16.8)
|
2.44 (2.00 - 2.98)
|
7 (4 - 10)
|
-2.3 (-5.6 - 1.1)
|
0.75 (0.46 - 1.22)
|
9 (8 - 10)
|
|
2006–2011
|
18 (15 - 21)
|
8.6 (5.6 - 11.6)
|
1.94 (1.60 - 2.34)
|
9 (6 - 13)
|
0.1 (-3.6 - 3.7)
|
1.01 (0.68 - 1.50)
|
9 (8 - 10)
|
|
Change p.a. (%)
| |
-1.36
| | |
-2.83
| | |
-2.54
|
|
P Trend
|
0.03
|
0.67
|
0.21
|
0.09
|
0.68
|
0.59
|
0.01
|
|
1981–1984
|
Suicide
|
3 (1 - 5)
|
-3.5 (-6.0 - -1.0)
|
0.45 (0.20 - 1.01)
| | | |
6 (5 - 8)
|
|
1986–1989
|
4 (2 - 6)
|
-2.5 (-4.8 - -0.1)
|
0.63 (0.38 - 1.06)
| | | |
7 (6 - 8)
|
|
1991–1994
|
4 (2 - 7)
|
-2.2 (-4.7 - 0.3)
|
0.66 (0.38 - 1.16)
|
3 (0 - 6)
|
-3.2 (-6.3 - -0.2)
|
0.50 (0.20 - 1.24)
|
6 (5 - 8)
|
|
1996–1999
|
10 (7 - 14)
|
3.9 (0.6 - 7.1)
|
1.59 (1.13 - 2.23)
|
6 (2 - 10)
|
-0.6 (-4.3 - 3.2)
|
0.91 (0.49 - 1.70)
|
7 (6 - 8)
|
|
2001–2006
|
8 (6 - 10)
|
1.7 (-0.4 - 3.9)
|
1.26 (0.97 - 1.65)
|
4 (2 - 6)
|
-3.0 (-5.2 - -0.7)
|
0.55 (0.31 - 0.99)
|
7 (6 - 7)
|
|
2006–2011
|
9 (7 - 11)
|
3.8 (1.7 - 5.9)
|
1.71 (1.32 - 2.20)
|
4 (2 - 6)
|
-1.1 (-3.1 - 0.8)
|
0.79 (0.50 - 1.24)
|
5 (5 - 6)
|
|
Change p.a. (%)
| |
4.89
| | |
-0.17
| | |
-0.47
|
|
P Trend
|
0.02
|
0.01
|
0.04
|
0.2
|
0.09
|
0.38
|
0.16
|
